The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call.
Oncology Institute Inc. (TOI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 3,360,052 | $1,098,401 | 0.01% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,725,562 | $564,086 | 0% | |
| 3. | FourWorld Capital Management John Addis | 257,000 | $84,013 | 0.04% | |
| 4. | Renaissance Technologies Jim Simons | 170,000 | $55,573 | -50% | 0% |
| 5. | 1,624,856 | $32,497 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.15 | 50,000 | Director | 666,753 | 2024-12-02 | Filing | |
| $0.17 | 250,000 | Director | 616,753 | 2024-11-26 | Filing | |
| $1.25 | 565 | Officer | 328,122 | 2023-12-14 | Filing | |
| $1.27 | 99,435 | Officer | 327,557 | 2023-12-14 | Filing | |
| $0.55 | 10,000 | Director | 257,193 | 2023-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.12 | 8,637 | 0 | 2024-01-29 | Filing | ||
| $2.14 | 6,979 | Large Shareholder | 8,637 | 2024-01-26 | Filing | |
| $2.07 | 11,882 | Large Shareholder | 15,616 | 2024-01-25 | Filing | |
| $2.30 | 24,915 | Large Shareholder | 27,498 | 2024-01-24 | Filing | |
| $2.11 | 5,338 | Large Shareholder | 52,413 | 2024-01-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,754,083 | $9,698,329 | 0% | |
| 2. | 1,856,329 | $3,786,911 | 3.61% | |
| 3. | 1,777,393 | $3,625,882 | 0% | |
| 4. | 699,500 | $1,426,980 | 0.02% | |
| 5. | 423,405 | $863,746 | 0.4% |
News See All
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2024 Earnings Call Transcript August 13, 2024The Oncology Institute, Inc. misses on earnings expectations.
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to The Oncology Institute's First Quarter 2024 Earnings Conference Call. Today's call is being recorded.
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript
The Oncology Institute, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.11.
Hedge Funds Say These Penny Stocks Are Poised to Explode
Despite common belief, not all penny stocks are inherently risky and suitable only for short-term gains.
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to The Oncology Institute Third Quarter 2023 earnings conference call.
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon ladies and gentlemen and welcome to The Oncology Institute's Second Quarter 2023 Earnings Conference Call.
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. Welcome to The Oncology Institute First Quarter 2023 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A.
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to The Oncology Institute's Fourth Quarter and Year-End 2022 Earnings Conference Call.
Billionaire Hedge Funds
